Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

生細胞イメージングの世界市場予測(~2023年)

◆タイトル:Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023
◆商品コード:BT 3390
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年2月20日
◆ページ数:159
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

生細胞イメージングの世界市場は、2018年の推定19億米ドルから2023年には29億米ドルに達し、この期間中8.9%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、創薬におけるハイコンテントスクリーニング技術の採用の増加、がんの発生率の上昇、および研究資金の増加が考えられます。一方で、ハイコンテントスクリーニングシステムの高コスト、熟練した専門家の不足などの要因により、市場の成長は抑制される可能性があります。当調査レポートでは、生細胞イメージングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(機器、消耗品、ソフトウェア、サービス)分析、用途(細胞生物学、幹細胞、創薬)分析、エンドユーザー(製薬会社・バイオテクノロジー企業、研究機関)分析、生細胞イメージングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The live cell imaging market is projected to grow at a CAGR of 8.9% during the forecast period.The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period. Market growth is largely driven by the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.

By product & service, the consumables segment is expected to grow at the highest rate during the forecast period.
On the basis of product and service, the global live cell imaging market is segmented into instruments, consumables, software, and services. The consumables segment is expected to grow at the highest CAGR during the forecast period. Unlike instruments, which are considered as a one-time investment, consumables are required to be purchased frequently. This is the major factor driving the growth of the live cell imaging consumables market. The increasing applications of live cell imaging assays and advancements in live cell imaging technologies are some of the other major factors that are driving the demand for live cell imaging consumables.

The pharmaceutical & biotechnology companies segment dominated the market in 2018.
On the basis of end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). In 2018, the pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market. The large share of this segment can be attributed to the increasing R&D activities and the patent cliff of various blockbuster drugs.

The Asia Pacific live cell imaging market is expected to grow at the highest CAGR during the forecast period.
Asia Pacific, comprising China, India, Japan, and Rest of Asia Pacific countries offers high-growth opportunities for players in the live cell imaging market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the Asia Pacific region are government initiatives for research on stem cell therapy, increasing aging population, rising prominence for regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–29%, Asia Pacific–23%, RoW–10%

The key players in the live cell imaging market are Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).
Research Coverage:
The report analyzes the live cell imaging market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the products and services offered by the top players in the live cell imaging market. The report analyzes the market based on product & service, application, end user, and region
• Product Development/Innovation: Detailed insights on new product launches in the live cell imaging market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various live cell imaging products and services across regions
• Market Diversification: Exhaustive information about products and services, untapped regions, recent developments, and investments in the live cell imaging market
• Competitive Assessment: In-depth assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 24
2.1.1.1 Key date from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Key industry insights 27
2.2 MARKET SIZE ESTIMATION 27
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 29
2.3 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 LIVE CELL IMAGING: MARKET OVERVIEW 36
4.2 LIVE CELL IMAGING MARKET, BY PRODUCT AND SERVICE, 2018 37
4.3 LIVE CELL IMAGING MARKET, BY APPLICATION, 2018 38
4.4 LIVE CELL IMAGING MARKET: GEOGRAPHIC SNAPSHOT 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising adoption of high-content screening techniques in drug discovery 41
5.2.1.2 Rising incidence of cancer 41
5.2.1.3 Growing availability of funds for research 41
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of high-content screening systems 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Emerging markets 42
5.2.3.2 Application of HCS in personalized medicine 43
5.2.4 CHALLENGES 44
5.2.4.1 Maintaining cell viability & cellular environment in the culture 44
5.2.4.2 Dearth of skilled professionals 44
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE 45
6.1 INTRODUCTION 46
6.2 INSTRUMENTS 47
6.2.1 INCREASING DEMAND FOR LIVE CELLS FOR ANALYSIS IN THE BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES TO DRIVE THE ADOPTION OF LIVE CELL IMAGING INSTRUMENTS 47
6.2.2 MICROSCOPES 48
6.2.3 STANDALONE SYSTEMS 50
6.2.4 CELL ANALYZERS 51
6.2.5 ACCESSORIES 51
6.3 CONSUMABLES 52
6.3.1 REAGENTS 53
6.3.1.1 Reagents segment to account for the largest share of the live cell imaging consumables market in 2018 53
6.3.2 ASSAY KITS 54
6.3.2.1 Repeat purchase of assay kits – key driver for market growth 54
6.3.3 MEDIA 55
6.3.3.1 Development of new and advanced technologies has resulted in an increased demand for high-quality media in biomedical research and processing 55
6.3.4 OTHER CONSUMABLES 56
6.4 SOFTWARE 57
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION – A KEY DRIVER FOR MARKET GROWTH 57
6.5 SERVICES 58
6.5.1 AVAILABILITY OF A WIDE RANGE OF SERVICES AND GROWING NUMBER OF INITIATIVES BY KEY PLAYERS TO DRIVE THE SERVICES MARKET 58
7 LIVE CELL IMAGING MARKET, BY APPLICATION 60
7.1 INTRODUCTION 61
7.2 CELL BIOLOGY 62
7.2.1 INCREASING PREVALENCE OF CANCER TO DRIVE THE CELL BIOLOGY APPLICATION SEGMENT 62
7.3 STEM CELLS 63
7.3.1 IMPORTANCE OF STEM CELL RESEARCH HAS BOOSTED INVESTMENTS IN THIS AREA 63

7.4 DEVELOPMENTAL BIOLOGY 64
7.4.1 GROWING RESEARCH IN DEVELOPMENTAL BIOLOGY A KEY DRIVER OF MARKET GROWTH 64
7.5 DRUG DISCOVERY 65
7.5.1 USE OF HCS CELL-BASED ASSAYS HAS GROWN IN DRUG DEVELOPMENT STUDIES 65
8 LIVE CELL IMAGING MARKET, BY END USER 67
8.1 INTRODUCTION 68
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 69
8.2.1 INCREASING R&D ACTIVITIES AND THE PATENT CLIFF OF VARIOUS BLOCKBUSTER DRUGS TO INCREASE THE DEMAND FOR LIVE CELL IMAGING PRODUCTS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69
8.3 ACADEMIC & RESEARCH INSTITUTES 70
8.3.1 DEMAND FOR LIVE CELL IMAGING PRODUCTS TO INCREASE IN ACADEMIC AND RESEARCH INSTITUTES OWING TO THE RISING FOCUS OF THESE END USERS ON STRENGTHENING THEIR OWN DRUG DISCOVERY RESEARCH PROGRAMS 70
8.4 CONTRACT RESEARCH ORGANIZATIONS 71
8.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR LIVE CELL IMAGING SYSTEMS IN CONTRACT RESEARCH ORGANIZATIONS 71
9 LIVE CELL IMAGING MARKET, BY REGION 72
9.1 INTRODUCTION 73
9.2 NORTH AMERICA 74
9.2.1 US 78
9.2.1.1 US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer 78
9.2.2 CANADA 80
9.2.2.1 Government initiatives to promote research and the need to combat cancer are the key factors driving the growth of the live cell imaging market in Canada 80
9.3 EUROPE 83
9.3.1 GERMANY 87
9.3.1.1 Presence of a large number of academic research institutes and increasing R&D spending to drive the demand for live cell imaging in Germany 87
9.3.2 UK 89
9.3.2.1 UK has seen a surge in the prevalence of cancer; by 2030, an estimated 4 million people are expected to be diagnosed with the disease 89
9.3.3 FRANCE 91
9.3.3.1 Growth in the French live cell imaging market is attributed to the large pharmaceutical manufacturing industry and the high public expenditure on R&D in France 91
9.3.4 REST OF EUROPE (ROE) 93
9.4 ASIA PACIFIC 96
9.4.1 CHINA 100
9.4.1.1 China to register the highest growth rate in the Asia Pacific live cell imaging market during the forecast period 100
9.4.2 JAPAN 102
9.4.2.1 Increasing aging population, rising prominence for regenerative medicine research, and increasing number of researchers to support market growth in Japan 102
9.4.3 INDIA 104
9.4.3.1 Favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry to drive market growth 104
9.4.4 ROAPAC 106
9.5 ROW 108
10 COMPETITIVE LANDSCAPE 113
10.1 INTRODUCTION 113
10.2 LIVE CELL IMAGING MARKET SHARE ANALYSIS (2017) 114
10.3 COMPETITIVE LEADERSHIP MAPPING 116
10.3.1 VISIONARY LEADERS 116
10.3.2 INNOVATORS 116
10.3.3 DYNAMIC DIFFERENTIATORS 116
10.3.4 EMERGING COMPANIES 117
10.4 COMPETITIVE SCENARIO 118
11 COMPANY PROFILES 120
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 DANAHER CORPORATION 120
11.2 CARL ZEISS AG 125
11.3 NIKON CORPORATION 128
11.4 OLYMPUS CORPORATION 131
11.5 PERKINELMER 133
11.6 GE HEALTHCARE 135
11.7 BRUKER 137
11.8 THERMO FISHER SCIENTIFIC 140
11.9 SARTORIUS AG 143
11.10 BIOTEK INSTRUMENTS 145
11.11 ETALUMA 147
11.12 CYTOSMART TECHNOLOGIES 149
11.13 NANOENTEK 150
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 151
12.1 DISCUSSION GUIDE: LIVE CELL IMAGING MARKET 151
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 155
12.3 AVAILABLE CUSTOMIZATIONS 157
12.4 RELATED REPORTS 157
12.5 AUTHOR DETAILS 158

LIST OF TABLES

TABLE 1 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 46
TABLE 2 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 47
TABLE 3 LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 48
TABLE 4 LIVE CELL IMAGING MICROSCOPES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 50
TABLE 5 LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 50
TABLE 6 LIVE CELL IMAGING CELL ANALYZERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 51
TABLE 7 LIVE CELL IMAGING ACCESSORIES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 52
TABLE 8 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 52
TABLE 9 LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 53
TABLE 10 LIVE CELL IMAGING REAGENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 54
TABLE 11 LIVE CELL IMAGING ASSAY KITS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 12 LIVE CELL IMAGING MEDIA MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 13 LIVE CELL IMAGING OTHER CONSUMABLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 14 LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 58
TABLE 15 LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 16 LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 61
TABLE 17 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY,
2016–2023 (USD MILLION) 62
TABLE 18 LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY,
2016–2023 (USD MILLION) 64
TABLE 19 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2016–2023 (USD MILLION) 65
TABLE 20 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY,
2016–2023 (USD MILLION) 66
TABLE 21 LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 68
TABLE 22 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 23 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 24 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 71
TABLE 25 LIVE CELL IMAGING MARKET, BY REGION, 2016–2023 (USD MILLION) 74
TABLE 26 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 76
TABLE 27 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 76
TABLE 28 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 77
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 77
TABLE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2016–2023 (USD MILLION) 78
TABLE 31 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 79
TABLE 32 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 33 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 80
TABLE 34 US: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 80
TABLE 35 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 81
TABLE 36 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 82
TABLE 37 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 82
TABLE 38 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 82
TABLE 39 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 85
TABLE 40 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 85
TABLE 41 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 86
TABLE 42 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 86
TABLE 43 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 87
TABLE 44 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 88
TABLE 45 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 88
TABLE 46 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 89
TABLE 47 GERMANY: LIVE CELL IMAGING MARKET, BY END USER,
2016–2023 (USD MILLION) 89
TABLE 48 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 90
TABLE 49 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 90
TABLE 50 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 91
TABLE 51 UK: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 91
TABLE 52 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 92
TABLE 53 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 92
TABLE 54 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 93
TABLE 55 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 93
TABLE 56 ROE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 94
TABLE 57 ROE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 95
TABLE 58 ROE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 95
TABLE 59 ROE: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 95
TABLE 60 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 98
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 98
TABLE 62 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 99
TABLE 63 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 99
TABLE 64 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2016–2023 (USD MILLION) 99
TABLE 65 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 100
TABLE 66 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 101
TABLE 67 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 101
TABLE 68 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 101
TABLE 69 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 102
TABLE 70 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 103
TABLE 71 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 103
TABLE 72 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 104
TABLE 73 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 105
TABLE 74 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 105
TABLE 75 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 106
TABLE 76 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 106
TABLE 77 ROAPAC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 107
TABLE 78 ROAPAC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 107
TABLE 79 ROAPAC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 108
TABLE 80 ROAPAC: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 108
TABLE 81 ROW: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 111
TABLE 82 ROW: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 111
TABLE 83 ROW: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 112
TABLE 84 ROW: LIVE CELL IMAGING MARKET, BY END USER, 2016–2023 (USD MILLION) 112

TABLE 85 PRODUCT LAUNCHES AND ENHANCEMENTS, 2015-2018 118
TABLE 86 AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS, 2015-2018 118
TABLE 87 ACQUISITIONS, 2015-2018 119
TABLE 88 EXPANSIONS, 2015-2018 119


LIST OF FIGURES

FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 19
FIGURE 2 LIVE CELL IMAGING MARKET: RESEARCH METHODOLOGY 22
FIGURE 3 RESEARCH DESIGN 23
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 26
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 28
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28
FIGURE 7 DATA TRIANGULATION METHODOLOGY 29
FIGURE 8 LIVE CELL IMAGING MARKET SHARE, BY PRODUCT AND SERVICE (2018) 31
FIGURE 9 MICROSCOPES SEGMENT HELD THE LARGEST SHARE OF THE LIVE CELL IMAGING INSTRUMENTS MARKET IN 2018 32
FIGURE 10 LIVE CELL IMAGING CONSUMABLES MARKET SHARE, BY TYPE (2018) 32
FIGURE 11 CELL BIOLOGY APPLICATIONS TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD 33
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD THE LARGEST SHARE OF THE LIVE CELL IMAGING MARKET IN 2018 34
FIGURE 13 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 35
FIGURE 14 GROWING ADOPTION OF HCS TECHNIQUES AND RISING INCIDENCE OF CANCER ARE KEY FACTORS DRIVING MARKET GROWTH 36
FIGURE 15 INSTRUMENTS DOMINATED THE NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2018 37
FIGURE 16 CELL BIOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN LIVE CELL IMAGING MARKET IN 2018 38
FIGURE 17 CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 39
FIGURE 18 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 40
FIGURE 19 INSTRUMENTS SEGMENT TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD 46
FIGURE 20 CELL BIOLOGY APPLICATIONS TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD 61
FIGURE 21 LIVE CELL IMAGING MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 68
FIGURE 22 LIVE CELL IMAGING MARKET, BY REGION, 2018 VS. 2023 (USD MILLION) 73
FIGURE 23 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 75
FIGURE 24 EUROPE: LIVE CELL IMAGING MARKET SNAPSHOT 84
FIGURE 25 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT 97
FIGURE 26 ROW: LIVE CELL IMAGING MARKET SNAPSHOT 110
FIGURE 27 KEY DEVELOPMENTS IN THE LIVE CELL IMAGING MARKET BETWEEN
2015 AND 2018 113
FIGURE 28 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 114
FIGURE 29 LIVE CELL IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP
MAPPING (2017) 117
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 121
FIGURE 31 CARL ZEISS AG: COMPANY SNAPSHOT (2017) 125
FIGURE 32 NIKON CORPORATION: COMPANY SNAPSHOT (2017) 128
FIGURE 33 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2017) 131
FIGURE 34 PERKINELMER: COMPANY SNAPSHOT (2017) 133
FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT (2017) 135
FIGURE 36 BRUKER: COMPANY SNAPSHOT (2017) 137
FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 140
FIGURE 38 SARTORIUS: COMPANY SNAPSHOT (2017) 143


★調査レポート[生細胞イメージングの世界市場予測(~2023年)] ( Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023 / BT 3390) 販売に関する免責事項
[生細胞イメージングの世界市場予測(~2023年)] ( Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023 / BT 3390) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆